Psoriasis | Chart Trends | US | 2014
ChartTrends®: Psoriasis 2014 (US) provides insight into the management and treatment of psoriasis patients by dermatologists based on actual patient-level data. More than 180 U.S. dermatologists were surveyed to compare what they self-report about disease management with what actually occurs at the patient level. Through an in-depth review of specific patient charts, details such as product dosing and frequency, prior medications, concomitant medications, and patient demographic variables help identify treatment approaches for psoriasis.
Related Market Assessment Reports
Report
Psoriatic Arthritis – Current Treatment – Treatment Algorithms: Claims Data Analysis – Psoriatic Arthritis (US)
Treatment of psoriatic arthritis (PsA) typically begins with conventional DMARDs, such as methotrexate, and progresses to more-potent biologics and/or targeted oral therapies as needed. The U.S…
Report
Painful Diabetic Neuropathy – Current Treatment – Treatment Algorithms: Claims Data Analysis – Painful Diabetic Neuropathy (US)
Painful diabetic neuropathy (PDN) is characterized by numbness, tingling, and burning, sharp, shooting, or other painful sensations, commonly in the feet, legs, and/or hands. PDN is managed with…
Report
Atopic Dermatitis / Atopic Eczema – Access & Reimbursement – Access & Reimbursement – Atopic Dermatitis (US)
The treatment landscape for AD in the United States is evolving rapidly. Since 2017, the FDA has approved multiple agents, including systemic and topical JAK inhibitors, nonsteroidal topical…
